Generic vs. Brand Name Drugs

November 3, 2011 | Nina | Comments (2)

Featured-series-banner-thought-exchange

 

 

Edward Lee RuffAs part of our on-going celebration of the International Year of Chemistry 2011, join us for our third lecture in the Chemistry Speaker Series by Dr. Edward Lee-Ruff.

Generic vs. Brand Name Drugs: Ongoing Patent Issues

 Wednesday, November 9, 6:30-8:00 pm

Toronto Reference Library, 789 Yonge St.

Beeton Auditorium, 1st floor

FREE!  ALL ARE WELCOME! Questions? Call Answerline 416-393-7131


Dr. Edward Lee-Ruff, Faculty of Science and Engineering, York University will discuss issues related to  brand name drugs and their generic equivalents such as government regulatory specifications, production costs, and patent issues (term of patent, re-patenting of "new forms" alias "re-inventing the wheel"). Some examples of specific drugs will be discussed.

Interested in doing some research before the talk? Read the Health Council of Canada's commissioned report Generic Drug Pricing and Access in Canada : What are the Implications? for an overview of why Canadians pay high prices for generics and recent changes that might make them more affordable. Some books at the Toronto Reference Library that discuss patent issues include Drug Patents under the Spotlight: Sharing Practical Knowledge about Pharmaceutical Patents published by Médecins sans Frontières and Regulating Bioprospecting : Institutions for Drug Research, Access, and Benefit-sharing.

 

Comments

2 thoughts on “Generic vs. Brand Name Drugs

  1. I am interested in attending/watching this talk (live or online). I have questions: how long is this talk and will this lecture be recorded and be available online.

    Reply

Leave a Comment

Your email address will not be published. Required fields are marked *

Generic vs. Brand Name Drugs

November 3, 2011 | Gillian | Comments (2)

Featured-series-banner-thought-exchange

 

 

Edward Lee RuffAs part of our on-going celebration of the International Year of Chemistry 2011, join us for our third lecture in the Chemistry Speaker Series by Dr. Edward Lee-Ruff.

Generic vs. Brand Name Drugs: Ongoing Patent Issues

 Wednesday, November 9, 6:30-8:00 pm

Toronto Reference Library, 789 Yonge St.

Beeton Auditorium, 1st floor

FREE!  ALL ARE WELCOME! Questions? Call Answerline 416-393-7131


Dr. Edward Lee-Ruff, Faculty of Science and Engineering, York University will discuss issues related to  brand name drugs and their generic equivalents such as government regulatory specifications, production costs, and patent issues (term of patent, re-patenting of "new forms" alias "re-inventing the wheel"). Some examples of specific drugs will be discussed.

Interested in doing some research before the talk? Read the Health Council of Canada's commissioned report Generic Drug Pricing and Access in Canada : What are the Implications? for an overview of why Canadians pay high prices for generics and recent changes that might make them more affordable. Some books at the Toronto Reference Library that discuss patent issues include Drug Patents under the Spotlight: Sharing Practical Knowledge about Pharmaceutical Patents published by Médecins sans Frontières and Regulating Bioprospecting : Institutions for Drug Research, Access, and Benefit-sharing.

 

Comments

2 thoughts on “Generic vs. Brand Name Drugs

  1. I am interested in attending/watching this talk (live or online). I have questions: how long is this talk and will this lecture be recorded and be available online.

    Reply

Leave a Comment

Your email address will not be published. Required fields are marked *